Company: PDEX
Filing Date: 2025-10-07
Form Type: DEF 14A
Source: 0001079973-25-001567
Chunk: 12

Company: PRO DEX INC
Filing Date: 2025-10-07
Form: DEF 14A
Chunk 12
---
 and a member of the Board of Directors of Versa Vascular, a venture-backed, privately held structural heart company
treating patients with tricuspid disease. He also serves as an Advisor at Stanford Medicine Catalyst, a Stanford University School of
Medicine program that supports health innovations. Previously, David served as Chief executive Officer of Innovein, Inc., a vascular company
focused on treating deep venous reflux disease, a position he held from January 2022 to August 2023. Prior to Innovein, Inc., he served
as Chief Executive Officer and a member of the Board of Directors of Simplify Medical, Inc., a privately held medical device company that
developed a cervical artificial disc replacement, from 2013 to 2021. In February 2021, Simplify Medical was acquired by Nuvasive, the
largest spine-focused company in the world. Prior to Simplify Medical, David was President, Chief Executive Officer and a member of the
Board of Directors of SpinalMotion, Inc., a privately held medical device company that designed, developed and marketed artificial discs
for use in the spine, from 2004 to 2013. Prior to joining SpinalMotion, he held leadership positions with Arthrocare, Inc. (Nasdaq: ARTC),
a developer and manufacturer of surgical devices, instruments, serving as the Vice President/General Manager of its Spine Division from
1999 to 2004, and as the Managing Director of its ENT Division from 1997 to 1999. From 1992 to 1997, David served in financial analysis
and product management positions with Medtronic, Inc. (NYSE: MDT), a multi-national medical technology company. He is an inventor on more
than 50 U.S. patents. David served for five years in the United States Navy, achieving the rank of Lieutenant. He received a Bachelor
of Science degree in Civil Engineering from Northwestern University and an M.B.A. from the Harvard Graduate School of Business Administration.
David has been a director of ours since January 2013.

| 5 |

David brings the following
experience, qualifications, attributes, and skills to our Board:

| · |     | Senior-level management, operating and board experience based on more than 20 years of participation                                      
 in the medical device industry, our primary target market, twelve years of which are specifically with medical devices to treat disorders 
 of the spine, a sector within the medical device industry that we